.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Covington
AstraZeneca
Mallinckrodt
Healthtrust
Cantor Fitzgerald
McKinsey
Teva
Boehringer Ingelheim

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076812

« Back to Dashboard
NDA 076812 describes ESTRADIOL AND NORGESTIMATE, which is a drug marketed by Barr and is included in one NDA. It is available from one supplier. Additional details are available on the ESTRADIOL AND NORGESTIMATE profile page.

The generic ingredient in ESTRADIOL AND NORGESTIMATE is estradiol; norgestimate. There are seventy-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estradiol; norgestimate profile page.

Summary for 076812

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 076812

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ESTRADIOL AND NORGESTIMATE
estradiol; norgestimate
TABLET;ORAL 076812 ANDA Teva Women's Health, Inc. 51285-063 51285-063-90 6 POUCH in 1 CARTON (51285-063-90) > 1 BLISTER PACK in 1 POUCH (51285-063-89) > 1 KIT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG,1MG;N/A,0.09MG
Approval Date:Apr 29, 2005TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Argus Health
Merck
Fuji
Mallinckrodt
US Department of Justice
UBS
McKesson
Moodys
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot